Scotia Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-18,871
| Closed | -$483K | – | 860 |
|
|
2024
Q3 | $483K | Buy |
+18,871
| New | +$483K | ﹤0.01% | 624 |
|
|
2024
Q2 | – | Sell |
-8,695
| Closed | -$250K | – | 830 |
|
|
2024
Q1 | $250K | Buy |
8,695
+1,339
| +18% | +$38.5K | ﹤0.01% | 721 |
|
|
2023
Q4 | $241K | Buy |
+7,356
| New | +$241K | ﹤0.01% | 704 |
|
|
2023
Q3 | – | Sell |
-6,994
| Closed | -$238K | – | 781 |
|
|
2023
Q2 | $238K | Sell |
6,994
-134
| -2% | -$4.57K | ﹤0.01% | 697 |
|
|
2023
Q1 | $214K | Sell |
7,128
-12
| -0.2% | -$361 | ﹤0.01% | 702 |
|
|
2022
Q4 | $202K | Sell |
7,140
-14,235
| -67% | -$402K | ﹤0.01% | 720 |
|
|
2022
Q3 | $703K | Buy |
21,375
+506
| +2% | +$16.6K | 0.01% | 497 |
|
|
2022
Q2 | $657K | Sell |
20,869
-271
| -1% | -$8.53K | ﹤0.01% | 528 |
|
|
2022
Q1 | $971K | Sell |
21,140
-28,577
| -57% | -$1.31M | 0.01% | 513 |
|
|
2021
Q4 | $3.05M | Sell |
49,717
-336
| -0.7% | -$20.6K | 0.02% | 333 |
|
|
2021
Q3 | $3.74M | Buy |
50,053
+3,177
| +7% | +$237K | 0.03% | 277 |
|
|
2021
Q2 | $4.34M | Buy |
46,876
+2,435
| +5% | +$225K | 0.03% | 258 |
|
|
2021
Q1 | $3.94M | Buy |
44,441
+22,427
| +102% | +$1.99M | 0.03% | 258 |
|
|
2020
Q4 | $2.05M | Buy |
22,014
+13,365
| +155% | +$1.25M | 0.02% | 317 |
|
|
2020
Q3 | $551K | Buy |
8,649
+1,064
| +14% | +$67.8K | 0.01% | 478 |
|
|
2020
Q2 | $396K | Buy |
+7,585
| New | +$396K | 0.01% | 461 |
|